Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

Published:2002-05-30 Issue:22 Volume:346 Page:1692-1698
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Herold Kevan C.,Hagopian William,Auger Julie A.,Poumian-Ruiz Ena,Taylor Lesley,Donaldson David,Gitelman Stephen E.,Harlan David M.,Xu Danlin,Zivin Robert A.,Bluestone Jeffrey A.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa012864

Cited by 1031 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From pre-clinical efficacy to promising clinical trials that delay Type 1 diabetes;Pharmacological Research;2024-10

2. Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial;Diabetes, Obesity and Metabolism;2024-08-27

3. Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: A systematic review;World Journal of Diabetes;2024-08-15

4. 12-Lipoxygenase inhibition suppresses islet immune and inflammatory responses and delays autoimmune diabetes in human gene replacement mice;2024-07-28

5. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis;World Journal of Diabetes;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP